Skip to main content

Advertisement

Log in

Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The objectives of this study were: (1) to describe parents and health care professionals (HCPs) perceived importance of oral mucositis prevention in children with cancer; (2) To describe utilities and willingness-to-pay (WTP) to prevent mucositis.

Methods

Respondents included parents of children receiving intensive chemotherapy for leukemia/lymphoma or undergoing stem cell transplantation and HCPs caring for children with cancer. Importance of mild and severe oral mucositis was estimated using a visual analogue scale (VAS). Mucositis-associated utilities were elicited using the time trade-off technique (TTO). WTP to avoid mucositis was obtained using contingent valuation. These techniques quantify how much time or money the participant is willing to relinquish in order to prevent mucositis.

Results

Eighty-two parents and 60 HCPs were included. Parents and HCPs believed mild mucositis to be of similar importance (median VAS 2.5 versus 3.6; P = 0.357) while parents considered severe mucositis less important than HCPs (median VAS 8.3 versus 9.0; P < 0.0001). No differences in parent versus HCP responses were seen with TTO (mild or severe mucositis) and most parents were not willing to trade any survival time to prevent severe mucositis. Parents were willing to pay significantly more than HCPs to prevent mild mucositis (average median WTP $1,371 CAN vs. $684 CAN, P = 0.031). No differences were seen in WTP to prevent severe mucositis.

Conclusions

Parents and HCP believe severe mucositis to be important, although it is more important to HCPs. Parents would not be willing to reduce life expectancy to eliminate mucositis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bellm LA, Cunningham G, Durnell L et al (2002) Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Investig 20:793–800

    Article  Google Scholar 

  2. Bennett K, Torrance G, Tugwell P (1991) Methodologic challenges in the development of utility measures of health-related quality of life in rheumatoid arthritis. Control Clin Trials 12:118S–128S

    Article  PubMed  CAS  Google Scholar 

  3. Bobinac A, Van Exel NJ, Rutten FF, Brouwer WB (2010) Willingness to pay for a quality-adjusted life-year: the individual perspective. Value Health 13:1046–1055

    Article  PubMed  Google Scholar 

  4. Carroll AE, Downs SM (2009) Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr 155:21–25, 25 e21–25

    Article  PubMed  Google Scholar 

  5. Cheng KK, Goggins WB, Lee VW, Thompson DR (2008) Risk factors for oral mucositis in children undergoing chemotherapy: a matched case–control study. Oral Oncol 44:1019–1025

    Article  PubMed  Google Scholar 

  6. Diez L (1998) Assessing the willingness of parents to pay for reducing postoperative emesis in children. Pharmacoeconomics 13:589–595

    Article  PubMed  CAS  Google Scholar 

  7. Donaldson C (2001) Eliciting patients’ values by use of ‘willingness to pay’: letting the theory drive the method. Heal Expect 4:180–188

    Article  CAS  Google Scholar 

  8. Donaldson C, Birch S, Gafni A (2002) The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes. Heal Econ 11:55–70

    Article  Google Scholar 

  9. Druley TE, Hayashi R, Mansur DB et al (2009) Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI. Bone Marrow Transplant 43:307–314

    Article  PubMed  CAS  Google Scholar 

  10. Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart G (2005) Methods for the economic evaluation of health care programmes. Oxfor University Press, Oxford

    Google Scholar 

  11. Elting LS, Cooksley CD, Chambers MS, Garden AS (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68:1110–1120

    Article  PubMed  Google Scholar 

  12. Figliolia SL, Oliveira DT, Pereira MC et al (2008) Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. Oral Dis 14:761–766

    Article  PubMed  CAS  Google Scholar 

  13. Froberg DG, Kane RL (1989) Methodology for measuring health-state preferences-I: measurement strategies. J Clin Epidemiol 42:345–354

    Article  PubMed  CAS  Google Scholar 

  14. Hanemann W (1984) Welfare evaluations in contingent valuation experiments with discrete responses. Am J Agric Econ 66:159–332

    Article  Google Scholar 

  15. Karthaus M, Rosenthal C, Ganser A (1999) Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis—are there new strategies? Bone Marrow Transplant 24:1095–1108

    Article  PubMed  CAS  Google Scholar 

  16. Lee SJ, Neumann PJ, Churchill WH, Cannon ME, Weinstein MC, Johannesson M (1997) Patients’ willingness to pay for autologous blood donation. Health Policy 40:1–12

    Article  PubMed  CAS  Google Scholar 

  17. Lee SK, Penner PL, Cox M (1991) Comparison of the attitudes of health care professionals and parents toward active treatment of very low birth weight infants. Pediatrics 88:110–114

    PubMed  CAS  Google Scholar 

  18. Lieu TA, Ray GT, Ortega-Sanchez IR, Kleinman K, Rusinak D, Prosser LA (2009) Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster. Pharmacoeconomics 27:1005–1016

    Article  PubMed  Google Scholar 

  19. Locatelli F, Testi AM, Bernardo ME et al (2009) Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia. Br J Haematol 147:371–378

    Article  PubMed  CAS  Google Scholar 

  20. Meyerhoff AS, Weniger BG, Jacobs RJ (2001) Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections. Pediatr Infect Dis J 20:S57–S62

    Article  PubMed  CAS  Google Scholar 

  21. Naraine VS, Risebrough NA, Oh P et al (2002) Health-related quality-of-life treatments for severe haemophilia: utility measurements using the Standard Gamble technique. Haemophilia 8:112–120

    Article  PubMed  CAS  Google Scholar 

  22. Neumann PJ, Johannesson M (1994) The willingness to pay for in vitro fertilization: a pilot study using contingent valuation. Med Care 32:686–699

    Article  PubMed  CAS  Google Scholar 

  23. Nonzee NJ, Dandade NA, Patel U et al (2008) Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis: results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer 113:1446–1452

    Article  PubMed  Google Scholar 

  24. Rhodes ET, Prosser LA, Lieu TA, Songer TJ, Ludwig DS, Laffel LM (2011) Preferences for type 2 diabetes health states among adolescents with or at risk of type 2 diabetes mellitus. Pediatr Diabetes (in press)

  25. Ryan M, Watson V (2009) Comparing welfare estimates from payment card contingent valuation and discrete choice experiments. Heal Econ 18:389–401

    Article  Google Scholar 

  26. Saigal S, Stoskopf BL, Feeny D et al (1999) Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA 281:1991–1997

    Article  PubMed  CAS  Google Scholar 

  27. Sonis ST (2007) Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 5:3–11

    PubMed  CAS  Google Scholar 

  28. Sonis ST, Oster G, Fuchs H et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205

    PubMed  CAS  Google Scholar 

  29. Spielberger R, Stiff P, Bensinger W et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590–2598

    Article  PubMed  CAS  Google Scholar 

  30. Von Neumann J, Morgenstern O (1953) Theory of games and economic behavior. Wiley, New York

    Google Scholar 

  31. Wasserfallen JB, Currat-Zweifel C, Cheseaux JJ, Hofer M, Fanconi S (2006) Parents’ willingness to pay for diminishing children’s pain during blood sampling. Paediatr Anaesth 16:11–18

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the assistance of Richard Wing, Tania Chung, and Celia Lai in terms of patient recruitment and data management. The project was supported by a Connaught New Staff Matching Grant from the University of Toronto. LS is supported by a New Investigator award from the Canadian Institutes of Health Research. This project was also possible due to the generous support of the employees of Kraft Canada Inc.

Conflict of interest

No conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lillian Sung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ethier, MC., Regier, D.A., Tomlinson, D. et al. Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer. Support Care Cancer 20, 1771–1777 (2012). https://doi.org/10.1007/s00520-011-1274-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-011-1274-x

Keywords

Navigation